DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» MTORC2
MTORC2
Cyclin-Dependent Kinases and Their Role in Inflammation, Endothelial Cell Migration
Newfound Coding Potential of Transcripts Unveils Missing Members Of
Cyclin-Dependent Kinases and CDK Inhibitors in Virus-Associated Cancers Shaian Tavakolian, Hossein Goudarzi and Ebrahim Faghihloo*
Title Mtorc1 Upregulation Via ERK-Dependent Gene Expression Change Confers Intrinsic Resistance to MEK Inhibitors in Oncogenic Kras-Mutant Cancer Cells
Synergy of WEE1 and Mtor Inhibition in Mutant KRAS-Driven
Mtorc2 Suppresses GSK3-Dependent Snail Degradation to Positively Regulate Cancer Cell Invasion and Metastasis
Protein-Protein Interactions Among Signaling Pathways May Become New Therapeutic Targets in Liver Cancer (Review)
Targeting Mtor Signaling Overcomes Acquired Resistance to Combined BRAF and MEK Inhibition in BRAF-Mutant Melanoma
PI3K Pathway Targets in Triple-Negative Breast Cancers
Insulin-Dependent Regulation of Mtorc2-Akt-Foxo Suppresses TLR4 Signaling in Human Leukocytes: Relevance to Type 2 Diabetes
Snapshot: Breast Cancer Kornelia Polyak and Otto Metzger Filho Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215 USA
Genome-Wide CRISPR-Cas9 Screens Reveal Loss of Redundancy Between PKMYT1 and WEE1 in Glioblastoma Stem-Like Cells
Combined Mtorc1/Mtorc2 Inhibition Blocks Growth and Induces Catastrophic Macropinocytosis in Cancer Cells
Tribbles Homolog 3-Mediated Targeting the AKT/Mtor Axis in Mice with Retinal Degeneration ✉ Irina V
Proteomic Survey Reveals Altered Energetic Patterns and Metabolic Failure Prior to Retinal Degeneration
Dual Targeting of BRAF and Mtor Signaling in Melanoma Cells with Pyridinyl Imidazole Compounds
Mtor Signaling Pathway and Mtor Inhibitors in Cancer: Progress and Challenges Zhilin Zou1,2,3†, Tao Tao4†, Hongmei Li3* and Xiao Zhu1,2*
Iκb Kinase Ε and TANK-Binding Kinase 1 Activate AKT by Direct Phosphorylation
Top View
Crosstalks of GSK3 Signaling with the Mtor Network and Effects on Targeted Therapy of Cancer T
Mtorc1 and Mtorc2 Expression Levels in Oral Squamous Cell
Targeted Therapies for Pancreatic Cancer: Overview of Current Treatments and New Opportunities for Personalized Oncology
BRAF Cooperates with PI3K Signaling, Independent of AKT, to Regulate
Mtorc2 Is a Tyrosine Kinase Cell Research (2016) 26:1-2
The Underlying Mechanism of Proinflammatory NF-Κb Activation by the Mtorc2/Akt/Ikkα Pathway During Skin Aging
PI3K/Akt Promotes Feedforward Mtorc2 Activation Through Ikkα
Regulation of Mtorc2 Signaling
(IKK) Α and Nuclear Factor-Κb (Nfκb)-Inducing Kinase (NIK) As Anti-Cancer Drug Targets
Snapshot: Breast Cancer Kornelia Polyak and Otto Metzger Filho Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215 USA
Identification of Wee1 As a Novel Therapeutic Target for Mutant RAS
Downloaded March
Mtorc1 Is Necessary but Mtorc2 and Gsk3β Are Inhibitory for AKT3- 3 Induced Axon Regeneration in the Central Nervous System
Mechanisms and Therapeutic Implications of GSK-3 in Treating Neurodegeneration
P27 Axis Through Mtorc2
PP2A As a Master Regulator of the Cell Cycle
Crosstalk Between the Mtor and DNA Damage Response Pathways in Fission Yeast
Effect of Damaging Rare Mutations in Synapse-Related Gene Sets On
The 3-Phosphoinositide-Dependent Protein Kinase 1 Inhibits Rod Photoreceptor Development
Akt: a New Activation Mechanism Cell Research (2014) 24:785-786
The Regulation of Mtorc2 Kinase Activity and Complex Integrity
ERK3 As a BRAF-Regulated Tumor Suppressor Is a New Potential Cancer Target in Melanoma
Twenty-Five Years of Mtor: Uncovering the Link from Nutrients to Growth
Snapshot: Mtor Signaling Alexandre Soulard and Michael N
BRAFV600E Negatively Regulates the AKT Pathway in Melanoma Cell Lines
Sequential Or Concomitant Inhibition of Cyclin-Dependent Kinase 4/6
Simultaneously Targeting DNA Damage Repair Pathway And
Regulation of Mrna Translation by Hormone Receptors in Breast and Prostate Cancer
Roles of Mtor Signaling in Tissue Regeneration
Neuroprotective Strategy in Retinal Degeneration: Suppressing ER Stress-Induced Cell Death Via Inhibition of the Mtor Signal
Original Article Mtor Inhibition Overcomes Primary and Acquired Resistance to Wee1 Inhibition by Augmenting Replication Stress in Epithelial Ovarian Cancers
The Impact of Mtorc2 Signaling on the Initiation and Progression of KRAS-Driven Pancreatic Neoplasias: a Dissertation
Targeting IKK in Cancer
Mtorc2 Suppresses GSK3-Dependent Snail
Synergy of WEE1 and Mtor Inhibition in Mutant KRAS-Driven Lung Cancers
Phosphoproteomics of MAPK Inhibition in BRAF-Mutated Cells and a Role for the Lethal Synergism of Dual BRAF and CK2 Inhibition
Proteins Affecting Rod Photoreceptor Differentiation in the Murine Retina: a Proteomics Approach with Emphasis on Mtor Alison Elizabeth Barnhill Iowa State University
Phosphorylation at Distinct Subcellular Locations Underlies Specificity in Mtorc2-Mediated Activation of SGK1 and Akt Catherine E